news Altering balance of fibroblasts could prevent spread of colorectal cancer 1 February 2021 | By Victoria Rees (Drug Target Review) Researchers have found that colorectal cancer-associated fibroblasts can be altered using a gremlin 1-neutralising antibody or by overexpressing meflin.
news Two compounds identified as circadian clock modulators 3 April 2020 | By Victoria Rees (Drug Target Review) Researchers have developed two small molecules which target two components of the circadian rhythm and could be used to lengthen the body clock.
news New protein function could be key to treatment of drug addiction 6 December 2019 | By Rachael Harper (Drug Target Review) Scientists have revealed new findings about the neural circuit involved in the reward stimulus, which plays a major role in drug dependence and psychological disorders.
news Cancer-suppressing cells identified in pancreatic cancer 14 October 2019 | By Rachael Harper (Drug Target Review) Cells containing Meflin play a role in restraining the progression of pancreatic cancer and could lead to new therapies against the disease.
article Five newest developments for imaging in drug research 12 August 2019 | By Victoria Rees (Drug Target Review) Imaging methods are used by scientists to identify therapeutic targets and improve drug efficacy. This article lists five of the latest developments for imaging techniques.
